TAFINLAR cpr disp 10 mg fl 210 pce
7680691350016
CH-69135
L01EC02
07.16.1.
1 / 3
google
Details
- Product number
- 6913501
- CPT
- -
- Packaging group
- 210
- Unit
- Tablette(n)
- Composition
- dabrafenibum 10 mg ut dabrafenibi mesilas, mannitolum, cellulosum microcristallinum, crospovidonum, hypromellosum, acesulfamum kalicum magnesii stearas, silica colloidalis anhydrica, aromatica Beerengeschmack alcohol benzylicus 0.00078 mg cum propylenglycolum 0.036 mg cum pro compresso.
Articles (1)
Tafinlar 10 mg, Tablette zur Herstellung einer Suspension zum Einnehmen
Tablette
210
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
10.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | AROMA |
|
(N/A)
|
0.00078 MG | Substance | HBESI |
|
(N/A)
|
0.036 MG | Substance | HBESI |
Authorization holder
Novartis Pharma Schweiz AG
6343 Risch
Authorization information
- Swissmedic authorization number
- 69135
- Drug name
- Tafinlar, Tablette zur Herstellung einer Suspension zum Einnehmen
- Galenic form
- TABSU
- ATC Code
- L01EC02
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 05/09/2023
- Authorization expiration date
- 04/09/2028
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- TAFINLAR cpr disp 10 mg fl 210 pce
- Description (DE)
- TAFINLAR Disp Tabl 10 mg Fl 210 Stk
- Market launch
- 05/09/2023
- Narcotic (BTM)
- No